Cyclophosphamide-induced nephrotoxicity, genotoxicity, and damage in kidney genomic DNA of Swiss albino mice: The protective effect of Ellagic acid

Molecular and Cellular Biochemistry

Volumn 365, Issue 1-2, 2012, Pages 119-127

  Rehman, Muneeb U ^a   Tahir, Mir ^a   Ali, Farrah ^a   Qamar, Wajhul ^a   Lateef, Abdul ^a   Khan, Rehan ^a   Quaiyoom, Abdul ^a   Oday O Hamiza, ^a   Sultana, Sarwat ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Cyclophosphamide; DNA damage; Ellagic acid; Genotoxicity; Nephrotoxicity

Indexed keywords

BIOLOGICAL MARKER; CATALASE; CREATININE; CYCLOPHOSPHAMIDE; ELLAGIC ACID; GENOMIC DNA; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; LACTATE DEHYDROGENASE; MALONALDEHYDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DNA FRAGMENTATION; DNA STRAND BREAKAGE; DRUG DOSE COMPARISON; ENZYME ACTIVITY; GENOTOXICITY; HISTOPATHOLOGY; KIDNEY INJURY; MALE; MICRONUCLEUS TEST; MOUSE; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; STATISTICAL SIGNIFICANCE; UREA NITROGEN BLOOD LEVEL;

ACUTE KIDNEY INJURY; ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTIOXIDANTS; BLOOD UREA NITROGEN; CREATININE; CYCLOPHOSPHAMIDE; DNA DAMAGE; ELLAGIC ACID; ERYTHROCYTES; GLUTATHIONE; KIDNEY; L-LACTATE DEHYDROGENASE; MALE; MICE; MICRONUCLEI, CHROMOSOME-DEFECTIVE; OXIDATION-REDUCTION; OXIDATIVE STRESS;

MUS;

EID: 84860239947     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-012-1250-x     Document Type: Article

References (60)

1. DJ Newman GM Cragg 2007 Natural products as sources of new drugs over the last 25 years J Nat Prod 70 461 477 17309302 10.1021/np068054v 1:CAS:528:DC%2BD2sXhvFKrsro%3D
2. LW Morton R Abu-Amsha Caccetta IB Puddey KD Croft 2000 Chemistry and biological effects of dietary phenolic compounds: relevance to cardiovascular disease Clin Exp Pharmacol Physiol 27 152 159 10744340 10.1046/j.1440-1681.2000. 03214.x 1:CAS:528:DC%2BD3cXitVaisr4%3D
3. Z Zhao Y Egashira H Sanada 2004 Ferulic acid is quickly absorbed from rat stomach as the free form and then conjugated mainly in liver J Nutr 134 3083 3088 15514279 1:CAS:528:DC%2BD2cXhtVSnsbnJ
4. Surh YJ (2003) Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 3:768-780
5. K Ippoushi A Takeuchi K Azuma 2009 Prevention of peroxynitrite-induced oxidation and nitration reactions by ellagic acid Food Chem 112 185 188 10.1016/j.foodchem.2008.05.057 1:CAS:528:DC%2BD1cXovFyjtL4%3D
6. SM Hannum 2004 Potential impact of strawberries on human health: a review of the science Crit Rev Food Sci Nutr 44 1 17 15077879 10.1080/ 10408690490263756 1:CAS:528:DC%2BD2cXisVWmt7o%3D
7. YH Heur W Zeng GD Stoner GA Nemeth B Hilton 1992 Synthesis of ellagic acid O-alkyl derivatives and isolation of ellagic acid as a tetrahexanoyl derivative from Fragaria ananassa J Nat Prod 55 1402 1407 1453178 10.1021/np50088a003 1:CAS:528:DyaK3sXjsFyqtg%3D%3D
8. S Mandal A Ahuja NM Shivapurkar SJ Cheng JD Groopman GD Stoner 1987 Inhibition of aflatoxin B1 mutagenesis in Salmonella typhimurium and DNA damage in cultured rat and human tracheobronchial tissues by ellagic acid Carcinogenesis 8 1651 1656 3117405 10.1093/carcin/8.11.1651 1:CAS:528: DyaL1cXitFOmt74%3D
9. Z Papoutsi E Kassi A Tsiapara N Fokialakis GP Chrousos P Moutsatsou 2005 Evaluation of estrogenic/antiestrogenic activity of ellagic acid via the estrogen receptor subtypes ERα and ERβ J Agric Food Chem 53 7715 7720 16190622 10.1021/jf0510539 1:CAS:528:DC%2BD2MXpsFaru78%3D
10. A Yuce A Ateşşahin AO CeribasI M Aksakal 2007 Ellagic acid prevents cisplatin induced oxidative stress in liver and heart tissue of rats Basic Clin Pharmacol Toxicol 101 345 349 17910619 10.1111/j.1742-7843.2007. 00129.x 1:CAS:528:DC%2BD2sXht1aisr3L
11. G Turk A Atessahin M Sonmez AO Ceribas A Yuce 2008 Improvement of cisplatin induced injuries to sperm quality, the oxidant-antioxidant system, and the histologic structure of the rat testis by ellagic acid Fertil Steril 89 1474 1481 17681317 10.1016/j.fertnstert.2007.04.059 1:CAS:528:DC%2BD1cXht12qsLbO
12. Y-M Yu W-C Chang C-H Wu S-Y Chiang 2005 Reduction of oxidative stress and apoptosis in hyperlipidemic rabbits by ellagic acid J Nutr Biochem 16 675 681 16081267 10.1016/j.jnutbio.2005.03.013 1:CAS:528:DC%2BD2MXhtFCjsLvM
13. A Atessahin AO Ceribaş A Yuce O Bulmus G Ckim 2007 Role of ellagic acid against cisplatin-induced nephrotoxicity and oxidative stress in rats Basic Clin Pharmacol Toxicol 100 121 126 17244261 10.1111/j.1742-7843.2007. 00060.x 1:CAS:528:DC%2BD2sXjt1Gkt7s%3D
14. JM Hwang JS Cho TH Kim YI Lee 2010 Ellagic acid protects hepatocytes from damage by inhibiting mitochondrial production of reactive oxygen species Biomed Pharmacother 64 264 270 20347566 10.1016/j.biopha.2009.06.013 1:CAS:528:DC%2BC3cXltFykur8%3D
15. AP Rogerio C Fontanari E Borducchi AC Keller M Rusco EG Soares DA Albuquerque LH Faccioli 2008 Anti-inflammatory effects of Lafoensia pacari and ellagic acid in a murine model of asthma Eur J Pharmacol 580 262 270 18021768 10.1016/j.ejphar.2007.10.034 1:CAS:528:DC%2BD1cXlt1ehtQ%3D%3D
16. JG de Boer H Yang J Holcroft K Skov 2004 Chemoprotection against N-nitrosomethylbenzylamine-induced mutation in the rat esophagus Nutr Cancer 50 168 173 15623463 10.1207/s15327914nc5002-6
17. D Ahn D Putt L Kresty GD Stoner D Fromm PF Hollenberg 1996 The effects of dietary ellagic acid on rat hepatic and esophageal mucosal cytochromes P450 and phase II enzymes Carcinogenesis 17 821 828 8625497 10.1093/carcin/17.4.821 1:CAS:528:DyaK28XislCgtr0%3D
18. AG Shepherd MM Manson HW Ball LI McLellan 2000 Regulation of rat glutamate-cysteine ligase (γ-glutamylcysteine synthetase) subunits by chemopreventive agents and in aflatoxin B1-induced preneoplasia Carcinogenesis 21 1827 1834 11023540 10.1093/carcin/21.10.1827 1:CAS:528:DC%2BD3cXnslKmt7c%3D
19. EM van der Logt HM Roelofs FM Nagengast WH Peters 2003 Induction of rat hepatic and intestinal UDP-glucuronosyltransferases by naturally occurring dietary anticarcinogens Carcinogenesis 24 1651 1656 12869420 10.1093/carcin/bgg117
20. F Baumann R Preiss 1973 Cyclophosphamide and related anticancer drugs J Chromatogr B 764 173 192
21. RE Fleming 1997 An overview of cyclophosphamide and ifosfamide pharmacology Pharmacotherapy 17 1465 1545
22. P Perini M Calabrese L Rinaldi P Gallo 2007 The safety profile of cyclophosphamide in multiple sclerosis therapy Expert Opin Drug Saf 6 183 190 17367264 10.1517/14740338.6.2.183 1:CAS:528:DC%2BD2sXjtFKnsrk%3D
23. WE Uber SE Self AB Van Bakel NL Pereira 2007 Acute antibody-mediated rejection following heart transplantation Am J Transplant 7 2064 2074 17614978 10.1111/j.1600-6143.2007.01900.x 1:STN:280:DC%2BD2svnvV2rsA%3D%3D
24. IARC (1987) IARC monograph on the evaluation of carcinogenicity: an update of IARC monographs 1 to 42. International Agency for Research on Cancer Supplement 7
25. BE Hales 1982 Comparison of the mutagenicity and teratogenicity of cyclophosphamide and its active metabolites, 4-hydroxycyclophosphamide, phosphoramide mustard and acrolein Cancer Res 42 3016 3021 7046914 1:CAS:528:DyaL38XltVeqtLY%3D
26. JM Patel 1987 Stimulation of cyclophosphamide-induced pulmonary microsomal lipid peroxidation by oxygen Toxicology 45 79 91 3603576 10.1016/0300-483X(87)90116-8 1:CAS:528:DyaL2sXlsVKqtL8%3D
27. DN Tripathi GB Jena 2008 Astaxanthin inhibits cytotoxic and genotoxic effects of cyclophosphamide in mice germ cells Toxicology 27 96 103 10.1016/j.tox.2008.03.015
28. LB Travis RE Curtis B Glimelius EJ Holowaty FE Van Leeuwen CF Lynch A Hagenbeek M Stovall PM Banks J Adami, et al. 1995 Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma J Natl Cancer Inst 87 524 530 7707439 10.1093/jnci/87.7.524 1:STN:280:DyaK2M3it1Kmuw%3D%3D
29. N Sladek 1971 Metabolism of cyclophosphamide by rat hepatic microsomes Cancer Res 1 901 908
30. NE Sladek 1988 Metabolism of oxazaphosphorines Pharmacol Ther 37 301 355 3290910 10.1016/0163-7258(88)90004-6 1:CAS:528:DyaL1cXlt1Wrs70%3D
31. P Roy LJ Yu CL Crespi DJ Waxman 1999 Development of a substrate-activity based approach to identify the major human liver P-450 catalysts of cyclophosphamide and ifosfamide activation based on cDNA-expressed activities and liver microsomal P-450 profiles Drug Metab Dispos 27 655 666 10348794 1:CAS:528:DyaK1MXjs1eltbY%3D
32. C Bagley F Bostick 2001 Clinical pharmacology of cyclophosphamide Cancer Res 33 226 235
33. SS Lin CF Hung CC Ho YH Liu HC Ho JG Chung 2000 Effects of Ellagic acid by oral administration on N-acetylation and metabolism of 2-aminofluorene in rat brain tissues Neurochem Res 25 11 1503 1508 11071370 10.1023/A:1007632326953 1:CAS:528:DC%2BD3cXnsFOktrk%3D
34. N Suzuki A Masamune K Kikuta T Watanabe K Satoh T Shimosegawa 2009 Ellagic acid inhibits pancreatic fibrosis in male Wistar Bonn/Kobori rats Dig Dis Sci 54 4 802 810 18651219 10.1007/s10620-008-0423-7 1:CAS:528: DC%2BD1MXisFSjtro%3D
35. L Levy R Harris 1977 Effect of N-acetyl cysteine on some aspects of cyclophosphamide induced toxicity and immunesupression Biochem Pharmacol 26 11 1015 1020 18149 10.1016/0006-2952(77)90237-4 1:CAS:528:DyaE2sXlt1Ohs7s%3D
36. P Chakraborty UH Sk N Murmu JK Das S Pal S Bhattacharya 2009 Modulation of cyclophosphamide-induced cellular toxicity by diphenylmethyl selenocyanate in vivo, an enzymatic study J Cancer Mol 4 6 183 189 1:CAS:528: DC%2BC3MXhtlyqt7o%3D
37. Nafees S, Tanveer S, Wani A, Rashid S, Ali N and Sultana S (2011) Modulatory effects of gentisic acid against genotoxicity and hepatotoxicity induced by cyclophosphamide in Swiss albino mice. J Pharm Pharmacol 64(2):259-267
38. W Schmid 1975 The micronucleus test Mutat Res 31 9 15 48190 1:CAS:528:DyaE2MXhtVOjs7Y%3D
39. B Gollapudi LG McFadden 1995 Sample size for the estimation of polychromatic to normochromatic erythrocyte ratio in the bone marrow micronucleus test Mutat Res 347 97 99 7651470 10.1016/0165-7992(95)90076-4 1:CAS:528:DyaK2MXmvVelurs%3D
40. M Tahir S Sultana 2011 Chrysin modulates ethanol metabolism in Wistar rats: a promising role against organ toxicities Alcohol Alcohol 46 383 392 21531755 1:CAS:528:DC%2BC3MXot1CksLo%3D
41. DJ Jollow JR Mitchell N Zampaglione JR Gillette 1974 Bromobenzene induced liver necrosis: protective role of glutathione and evidence for 3,4-bromobezene oxide as the hepatotoxic metabolite Pharmacology 11 151 4831804 10.1159/000136485 1:CAS:528:DyaE2cXkslejtLk%3D
42. I Carlberg B Mannervik 1985 Glutathione level in rat brain J Biol Chem 250 4480 4575
43. M Mohandas JJ Marshall GG Duggin JS Horvath D Tiller 1984 Differential distribution of glutathione and glutathione related enzymes in rabbit kidney Cancer Res 44 5086 5091 6149017 1:CAS:528:DyaL2cXmt1Oqsro%3D
44. WH Habig MJ Pabst WB Jakoby 1974 Glutathione-S-transferases: the first enzymatic step in mercapturic acid formation J Biol Chem 249 7130 7139 4436300 1:CAS:528:DyaE2MXltlahtg%3D%3D
45. JR Wright HD Colby PR Miles 1981 Cytosolic factors which affect microsomal lipid peroxidation in lung and liver Arch Biochem Biophys 206 296 304 7224639 10.1016/0003-9861(81)90095-3 1:CAS:528:DyaL3MXpvVersw%3D%3D
46. F Stripe E Della Corte 1969 The regulation of rat liver xanthine oxidase J Biol Chem 244 3855 3863
47. Claiborne A (1985) Catalase activity. In: Greenwald RA (ed) CRC handbook of methods in oxygen radical research. CRC Press, Boca Raton, pp 283-284
48. Kornberg A (1955) Lactic dehydrogenase of muscle. In: Colowick SP, Kaplan NO (eds) Methods in enzymology, vol I. Academic Press, New York, pp 441-443
49. OH Lowry NJ Rosebrough A Farr RJ Randall 1951 Protein measurement with the Folin phenol reagent J Biol Chem 193 265 275 14907713 1:CAS:528: DyaG38XhsVyrsw%3D%3D
50. JG Hengstler A Hengst J Fuchs B Tanner J Pohl F Oesch 1997 Induction of DNA cross links and DNA strand lesions by cyclophosphamide after inactivation by cytochrome P-450 2B1 Mutat Res 373 215 223 9042403 10.1016/S0027-5107(96)00200- X 1:CAS:528:DyaK2sXmsV2hsw%3D%3D
51. R Haque B Bin-Hafeez S Parvez S Pandey I Sayeed M Ali S Raisuddin 2003 Aqueous extract of walnut (Juglans regia L.) protects mice against cyclophosphamide-induced biochemical toxicity Hum Exp Toxicol 22 473 480 14580007 10.1191/0960327103ht388oa 1:STN:280:DC%2BD3srgt1GhtQ%3D%3D
52. E Selvakumar C Prahalathan Y Mythili P Varalakshmi 2005 Mitigation of oxidative stress in cyclophosphamide-challenged hepatic tissue by dl-alpha-lipoic acid Mol Cell Biochem 272 179 185 16010986 10.1007/s11010-005- 7322-4 1:CAS:528:DC%2BD2MXjvV2kt7k%3D
53. JA Cooper WW Merrill HY Reynolds 1986 Cyclophosphamide modulation of bronchoalveolar cellular populations and macrophage oxidative metabolism: possible mechanisms of pulmonary pharmacotoxicity Am Rev Respir Dis 134 108 114 3014931 1:CAS:528:DyaL28XkvFSqtrk%3D
54. JP Kehrer SS Biswal 2000 The molecular effects of acrolein Toxicol Sci 57 6 15 10966506 10.1093/toxsci/57.1.6 1:CAS:528:DC%2BD3cXmslyls7g%3D
55. DN Tripathi GB Jena 2009 Intervention of astaxanthin against cyclophosphamide-induced oxidative stress and DNA damage: a study in mice Chem Biol Interact 180 398 406 19539803 10.1016/j.cbi.2009.03.017 1:CAS:528:DC%2BD1MXnsFaku7s%3D
56. K Bhatia M Kaur F Atif M Ali H Rehman S Rahman S Raisuddin 2006 Aqueous extract of Trigonella foenum-graecum L. ameliorates additive urotoxicity of buthionine sulfoximine and cyclophosphamide in mice Food Chem Toxicol 44 1744 1750 16828947 10.1016/j.fct.2006.05.013 1:CAS:528:DC%2BD28XotlKrurk%3D
57. K Cagler C Kinalp F Arpaci M Turan K Saglam B Ozturk S Komurcu Yavuz M Yenicesu A Ozet A Vural 2002 Cumulative prior dose of cisplatin as a cause of the nephrotoxicity of high-dose chemotherapy followed by autologous stem-cell transplantation Nephrol Dial Transplant 17 1931 1935 10.1093/ndt/17.11.1931
58. P Abrahama K Indiranib E Sugumar 2007 Effect of cyclophosphamide treatment on selected lysosomal enzymes in the kidney of rats Exp Toxicol Pathol 59 143 149 10.1016/j.etp.2007.05.003
59. Salamone MF, Heddle JA (1983) The bone marrow micronucleus assay: rationale for a revised protocol. In: de Serres FJ (ed) Chemical mutagens: principles and methods for their detection, vol 8. Plenum, New York, pp 111-149
60. AA Al-Majed AA Al-Yahya AM Al-Bekairi OA Al-Shabanah S Qureshi 2006 Studies on the cytological and biochemical effects of valerian in somatic and germ cells of Swiss albino mice Food Chem Toxicol 44 1830 1837 16879905 10.1016/j.fct.2006.06.001 1:CAS:528:DC%2BD28XpvFGmsro%3D